Deciphering the lipid–cancer nexus: comprehensive Mendelian randomization analysis of the associations between lipid profiles and digestive system cancer susceptibility

Background Digestive system cancers represent a significant global health challenge and are attributed to a combination of demographic and lifestyle changes.

Lipidomics has emerged as a pivotal area in cancer research, suggesting that alterations in lipid metabolism are closely linked to cancer development.

However, the causal relationship between specific lipid profiles and digestive system cancer risk remains unclear.

Methods Using a two-sample Mendelian randomization (MR) approach, we elucidated the causal relationships between lipidomic profiles and the risk of five types of digestive system cancer: stomach, liver, esophageal, pancreatic, and colorectal cancers.

The aim of this study was to investigate the effect impact of developing lipid profiles on the risk of digestive system cancers utilizing data from public databases such as the GWAS Catalog and the UK Biobank.

The inverse‒variance weighted (IVW) method and other strict MR methods were used to evaluate the potential causal links.

In addition, we performed sensitivity analyses and reverse MR analyses to ensure the robustness of the results.

Results Significant causal relationships were identified between certain lipidomic traits and the risk of developing digestive system cancers.

Elevated sphingomyelin (d40:1) levels were associated with a reduced risk of developing gastric cancer (odds ratio (OR) = 0.68, P  < 0.001), while elevated levels of phosphatidylcholine (16:1_20:4) increased the risk of developing esophageal cancer (OR = 1.31, P  = 0.02).

Conversely, phosphatidylcholine (18:2_0:0) had a protective effect against colorectal cancer (OR = 0.86, P  = 0.036).

The bidirectional analysis did not suggest reverse causality between cancer risk and lipid levels.

Strict MR methods demonstrated the robustness of the above causal relationships.

Conclusion Our findings underscore the significant causal relationships between specific lipidomic traits and the risk of developing various digestive system cancers, highlighting the potential of lipid profiles in informing cancer prevention and treatment strategies.

These results reinforce the value of MR in unraveling complex lipid-cancer interactions, offering new avenues for research and clinical application.